CClinicalTrials.gg
Status unknownNCT00641368R4PowerUpdated Mar 24, 2008

R4Power: An Online Resilience Program for Adolescents

A Phase 1 interventional study of R4Power Program and Waitlist Control in Depression and Anxiety, sponsored by Swarthmore College. Status unknown at 1 site in United States. Open to participants aged 11 Years to 15 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2008-03-24.

Sponsored by Swarthmore College · Phase 1, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Mar 2008), so the status shown — last known as Recruiting — may be out of date.
Phase
Phase 1
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
11 Years to 15 Years
Sex
All
01

Study summary

The study will evaluate the R4Power program, an online intervention designed to teach adolescents coping and problem-solving skills.

Read the detailed description

This study examines the feasibility of a 10-lesson web-based intervention, the R4Power program, and its effectiveness in preventing symptoms of depression and anxiety. The R4Power Program teaches cognitive and problem-solving skills covered in classroom based interventions, including the Penn Resiliency Program, that have been found to reduce or prevent symptoms of depression in children and adolescents. This study examines whether adolescents can benefit from learning these skills through a computer (rather than classroom) intervention.

Adolescents in grades 6 through 8 who participate in this study will be assigned to one of two conditions: an intervention group that will complete the R4Power program during the first year (R4Power1), or a waitlist control group that will complete the R4Power program the following year (R4Power2). Students will complete the 10-lesson program over the course of twelve weeks. They will learn and practice cognitive skills (recognizing the link between their thoughts and feelings, identifying thinking traps, challenging their negative beliefs) and problem-solving skills (assertiveness, relaxation and distraction, overcoming procrastination, and decision making). Adolescents who participate in this study will be followed for one year, and their coping responses and symptoms of depression and anxiety will be assessed at four points: at the beginning of the study (baseline) and at follow-up assessments approximately 4, 12 and 16 months after baseline.

02

Conditions studied

  • Depression
  • Anxiety

Browse trials for

Keywords

  • Adolescent
  • Child
  • Computer
  • Depression
  • Resilience
03

In context

Depression

8,057 studies on the registry are indexed under Depression; 1,641 are open to participants now.

This study's planned enrollment of 200 is above the median of 84 across 6,720 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

Swarthmore College is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Years to 15 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • 6th-8th grade students attending participating school OR adolescents aged 11-15 living in greater Philadelphia area
  • Access to high speed internet connection (at home, school, or another location)

Exclusion criteria

Exclusion Criteria:

  • Below 6th grade reading level, as reported by parents
05

Study design

Phase
Phase 1
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    1

    R4Power Program

    Behavioral: R4Power Program

  • Other
    2

    Waitlist Control

    Other: Waitlist Control

Interventions

  • BehavioralR4Power Program

    In the 10-lesson online R4Power Program, adolescents will learn cognitive skills (link between thoughts, feelings, and behaviors; thinking traps; challenging negative beliefs) and problem-solving skills (assertiveness; relaxation and distraction; overcoming procrastination; decision-making) in order to cope with stressful situations.

    Also known as: R4Power1

  • OtherWaitlist Control

    Adolescents in the waitlist control group will complete the R4Power program during the second year of the study.

    Also known as: R4Power2

06

What researchers measure

Primary outcomes

  1. Adolescents' coping strategies by self-report

    Time frame: Measured at baseline and follow-ups approximately 4, 12, and 16 months after baseline

  2. Adolescents' depressive symptoms by self-report

    Time frame: Measured at baseline and follow-ups approximately 4, 12, and 16 months after baseline

Secondary outcomes

  1. Adolescents' symptoms of anxiety by self-report

    Time frame: Measured at baseline and follow-ups approximately 4, 12, and 16 months after baseline

07

Study locations

1 of 1 sites recruiting
  • Swarthmore College
    Swarthmore, Pennsylvania 19081, United States
    • Jane E. Gillham, Ph.D. · Contact · info@positivepsych.org · 610-957-6010
    • Jane E. Gillham, Ph.D. · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 24, 2008, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00641368
Lead sponsor
Swarthmore College
First posted
Mar 24, 2008
Start date
Oct 2007
Primary completion
Oct 2009 (estimated)
Completion
Oct 2009 (estimated)
Last update
Mar 24, 2008

Study contacts

Jane E. Gillham, Ph.D.
Contact
info@positivepsych.org
610-957-6010
Jane E. Gillham, Ph.D.
principal investigator · Swarthmore College
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion